Leidos Holdings, Inc. $LDOS Shares Purchased by United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund

United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund raised its position in Leidos Holdings, Inc. (NYSE:LDOS) by 120.4% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 11,900 shares of the aerospace company’s stock after purchasing an additional 6,500 shares during the quarter. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund’s holdings in Leidos were worth $2,249,000 as of its most recent SEC filing.

A number of other large investors also recently added to or reduced their stakes in LDOS. Harbor Capital Advisors Inc. grew its stake in shares of Leidos by 2.7% in the third quarter. Harbor Capital Advisors Inc. now owns 2,203 shares of the aerospace company’s stock valued at $416,000 after buying an additional 57 shares in the last quarter. Personal CFO Solutions LLC lifted its stake in Leidos by 2.0% during the 2nd quarter. Personal CFO Solutions LLC now owns 2,974 shares of the aerospace company’s stock worth $469,000 after acquiring an additional 59 shares in the last quarter. Beacon Pointe Advisors LLC lifted its stake in Leidos by 3.7% during the 2nd quarter. Beacon Pointe Advisors LLC now owns 1,639 shares of the aerospace company’s stock worth $259,000 after acquiring an additional 59 shares in the last quarter. Atlantic Union Bankshares Corp boosted its holdings in Leidos by 0.7% during the 3rd quarter. Atlantic Union Bankshares Corp now owns 8,243 shares of the aerospace company’s stock valued at $1,558,000 after acquiring an additional 61 shares during the period. Finally, CX Institutional boosted its holdings in Leidos by 4.3% during the 3rd quarter. CX Institutional now owns 1,503 shares of the aerospace company’s stock valued at $284,000 after acquiring an additional 62 shares during the period. 76.12% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

LDOS has been the topic of a number of recent research reports. Jefferies Financial Group reiterated a “buy” rating and set a $215.00 price target on shares of Leidos in a research note on Monday, February 23rd. Royal Bank Of Canada lowered their price objective on shares of Leidos from $230.00 to $215.00 and set an “outperform” rating for the company in a research note on Wednesday, February 18th. Robert W. Baird dropped their price objective on shares of Leidos from $215.00 to $195.00 and set a “neutral” rating for the company in a report on Wednesday, February 18th. Citigroup upped their target price on shares of Leidos from $218.00 to $232.00 and gave the stock a “buy” rating in a research note on Tuesday, January 13th. Finally, Wall Street Zen lowered shares of Leidos from a “strong-buy” rating to a “hold” rating in a report on Saturday, February 21st. Nine analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $214.18.

Leidos Trading Up 1.4%

LDOS opened at $178.10 on Friday. Leidos Holdings, Inc. has a one year low of $128.32 and a one year high of $205.77. The company has a market cap of $22.51 billion, a P/E ratio of 16.00, a PEG ratio of 1.26 and a beta of 0.63. The company has a debt-to-equity ratio of 0.93, a quick ratio of 1.58 and a current ratio of 1.70. The business’s 50-day simple moving average is $184.76 and its 200-day simple moving average is $186.54.

Leidos (NYSE:LDOS) last issued its earnings results on Tuesday, February 17th. The aerospace company reported $2.76 earnings per share for the quarter, topping the consensus estimate of $2.57 by $0.19. The business had revenue of $4.21 billion for the quarter, compared to analyst estimates of $4.31 billion. Leidos had a return on equity of 32.95% and a net margin of 8.43%.The business’s quarterly revenue was down 3.6% on a year-over-year basis. During the same quarter last year, the company earned $2.37 EPS. Leidos has set its FY 2026 guidance at 12.050-12.450 EPS. As a group, equities research analysts expect that Leidos Holdings, Inc. will post 10.62 EPS for the current fiscal year.

Leidos Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Monday, March 16th will be given a $0.43 dividend. The ex-dividend date of this dividend is Monday, March 16th. This represents a $1.72 dividend on an annualized basis and a yield of 1.0%. Leidos’s payout ratio is 15.45%.

Insider Transactions at Leidos

In other Leidos news, insider Elizabeth A. Porter sold 3,000 shares of the firm’s stock in a transaction dated Tuesday, January 20th. The stock was sold at an average price of $192.21, for a total transaction of $576,630.00. Following the transaction, the insider owned 38,575 shares of the company’s stock, valued at approximately $7,414,500.75. This trade represents a 7.22% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.96% of the stock is owned by corporate insiders.

Leidos Company Profile

Leidos is an American technology and engineering company that provides services and solutions to government and commercial customers, with a strong focus on national security, defense, intelligence, and civil government markets. The company delivers systems integration, engineering, cybersecurity, software development, data analytics, cloud migration and managed IT services, as well as mission support for complex programs. Leidos’ work spans areas such as C4ISR (command, control, communications, computers, intelligence, surveillance and reconnaissance), secure communications, sensors and systems engineering, and health IT solutions for public-sector healthcare programs.

Leidos traces its corporate roots to Science Applications International Corporation (SAIC) and emerged as an independent, publicly traded company following a corporate separation in 2013.